CLN5 and diabetes mellitus: As noted above, metformin may confer skeletal benefits through activation of AMPK signaling and support of osteoblast differentiation [14] that may have impacted the BMP levels; therefore baseline changes in BMPs cannot be definitively attributed to diabetes.